Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review. - Wikidata - awgldk - TriplyDB

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

http://www.wikidata.org/entity/Q35079338

about

Correlations of post-implant regional dosimetric parameters at 24 hours and one month, with clinical results of low-dose-rate brachytherapy for localized prostate cancer.[Localized prostate cancer: Radiotherapeutic concepts].A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.

P2860

Q49337046-CA22A534-547C-4CCB-95F2-5ED9422A6CF6 Q53170443-096F89C3-FBFD-414A-9632-D41AC0B63417 Q55246874-6B749741-6EDE-423B-935C-8B51C23FD587

P2860

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

http://www.wikidata.org/entity/Q35079338

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@ast

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@en

type

label

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@ast

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@en

prefLabel

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@ast

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@en

P1433

Q35079338-4819985A-87A2-4FD5-AEA6-F54B340439A3

P1476

Q35079338-7E7451EE-3F55-4831-95DC-5512475A6738

P2093

Q35079338-6B4E77AB-1697-469A-9558-D56D68D6277D

Q35079338-6CDBF7A3-211B-47F0-9565-0940873258DC

Q35079338-9C077496-E371-479E-B234-5B14DBB5A4A9

Q35079338-ACC9BEF5-0F52-4EDA-AA88-0CE7A6A10C7E

Q35079338-F2696BD5-CBD2-441D-98D0-5800EBE51E3E

P2860

Q35079338-044E330F-A17D-477D-A2EC-33022029DBC4

Q35079338-0BA0D2F8-269A-4EC0-B3C7-0CAD020085A4

Q35079338-136B85D6-96D9-40DE-8D45-1D33A8170465

Q35079338-21F712BA-8AF2-44E8-A1D6-8F8DC2AA5E5B

Q35079338-2237E7D2-6FD1-4351-8FE9-D3654EF929C2

Q35079338-256B9524-64DE-4E37-AD58-DADF66D0F6FC

Q35079338-301AD171-9E1D-4C85-BC08-931C20EBF501

Q35079338-392AE8E1-81A7-4738-AD13-65A5B1EFED0A

Q35079338-39783B79-E27B-4046-9335-9126937CF64F

Q35079338-3CB09ABA-3287-42B5-B5DF-2375323BC930

P304

Q35079338-229C0662-781C-451F-AB8F-054D57F7C92E

P31

Q35079338-E422BFEC-8719-46F0-9908-9A833CC746A4

P356

Q35079338-A41850D5-79DB-47B8-9A3E-6D8EEB0149C1

P433

Q35079338-84678611-489E-416E-9B68-C459FE6FE205

P478

Q35079338-00040A49-F9BA-4922-B0FA-AC44E4F450F5

P577

Q35079338-D867CD9E-E507-41D1-84ED-FF2C37A7C42C

P5875

Q35079338-2F0E20CB-D040-4521-B485-06AF3B5C881D

P698

Q35079338-F7AA5C70-829C-49E0-B7B8-581F7ECC7FE5

P921

Q35079338-6C79C801-713E-476A-9530-DF6FA88CACD0

P932

Q35079338-46F66356-7270-442C-9BCA-0CF5DD630405

P356

P1433

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

P1476

Low-dose rate brachytherapy fo ...... e cancer: A systematic review.

@en

P2093

D Andrew Loblaw

http://www.w3.org/2001/XMLSchema#string

George Rodrigues

http://www.w3.org/2001/XMLSchema#string

Joseph L Chin

http://www.w3.org/2001/XMLSchema#string

Michael Brundage

http://www.w3.org/2001/XMLSchema#string

Xiaomei Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Low-dose rate brachytherapy for men with localized prostate cancer

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis.

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.

Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review.

P304

463-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5489/CUAJ.1482

http://www.w3.org/2001/XMLSchema#string

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259530445

http://www.w3.org/2001/XMLSchema#string

P698

24381672

http://www.w3.org/2001/XMLSchema#string

P921

P932

3876453

http://www.w3.org/2001/XMLSchema#string